Wang X, Lin X, Loy J A, Tang J, Zhang X C
Crystallography Program, Oklahoma Medical Research Foundation, 825 N.E. 13th Street, Oklahoma City, OK 73104, USA.
Science. 1998 Sep 11;281(5383):1662-5. doi: 10.1126/science.281.5383.1662.
Streptokinase is a plasminogen activator widely used in treating blood-clotting disorders. Complexes of streptokinase with human plasminogen can hydrolytically activate other plasminogen molecules to plasmin, which then dissolves blood clots. A similar binding activation mechanism also occurs in some key steps of blood coagulation. The crystal structure of streptokinase complexed with the catalytic unit of human plasmin was solved at 2.9 angstroms. The amino-terminal domain of streptokinase in the complex is hypothesized to enhance the substrate recognition. The carboxyl-terminal domain of streptokinase, which binds near the activation loop of plasminogen, is likely responsible for the contact activation of plasminogen in the complex.
链激酶是一种广泛用于治疗凝血障碍的纤溶酶原激活剂。链激酶与人纤溶酶原的复合物可将其他纤溶酶原分子水解激活为纤溶酶,纤溶酶进而溶解血凝块。类似的结合激活机制也出现在血液凝固的一些关键步骤中。链激酶与人纤溶酶催化单元复合物的晶体结构在2.9埃分辨率下得到解析。复合物中链激酶的氨基末端结构域被推测可增强底物识别。链激酶的羧基末端结构域结合在纤溶酶原激活环附近,可能负责复合物中纤溶酶原的接触激活。